Stocks
Cara Therapeutics (CARA) ROA US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| ROA, % | ? | 3.10% | -35.7% | -45.8% | -94.2% | -94.2% | -186.1% | ||
| Changes by years, y/y, % | +49pp | -39pp | -10pp | -48pp | 0pp | +19.4% | |||
Cara Therapeutics. ROA, %
Cara Therapeutics. ROA, changes, pp
Cara Therapeutics (CARA) ROA US GAAP (quarter values) |
||||||||
| 2023Q4 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| ROA, % | ? | -93.4% | -93.4% | -136.0% | -153.2% | -186.1% | -186.1% | |
| Changes by years, y/y, % | -48pp | -48pp | -83pp | -72pp | -87pp | |||
| Changes by quarters, q/q, % | +6pp | 0pp | -43pp | -17pp | -33pp | |||
